Cargando…
Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641864/ https://www.ncbi.nlm.nih.gov/pubmed/33148334 http://dx.doi.org/10.1186/s13287-020-01972-5 |
_version_ | 1783606013211967488 |
---|---|
author | Zhao, Yan Ma, Jiao Yi, Peiye Wu, Jun Zhao, Feiyan Tu, Wan Liu, Wenjing Li, Tianda Deng, Yan Hao, Jie Wang, Hongmei Yan, Long |
author_facet | Zhao, Yan Ma, Jiao Yi, Peiye Wu, Jun Zhao, Feiyan Tu, Wan Liu, Wenjing Li, Tianda Deng, Yan Hao, Jie Wang, Hongmei Yan, Long |
author_sort | Zhao, Yan |
collection | PubMed |
description | BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and mechanism of it remain unclear. METHODS: POI mice model was generated by cyclophosphamide and busulfan, followed with the treatment of tail-vein injection of the human umbilical cord mesenchymal stem cells (hUCMSCs). Maternal physiological changes and offspring behavior were detected. To reveal the pathogenesis and therapeutic mechanisms of POI, we first compared the metabolite profiles of healthy and POI ovarian tissues using untargeted metabolomics analyses. After stem cell therapy, we then collected the ovaries from control, POI, and hUCMSC-treated POI groups for lipid metabolomics and pseudotargeted metabolomics analysis. RESULTS: Our results revealed remarkable changes of multiple metabolites, especially lipids, in ovarian tissues after POI generation. Following the transplantation of clinical-grade hUCMSCs, POI mice exhibited significant improvements in body weight, sex hormone levels, estrous cycles, and reproductive capacity. Lipid metabolomics and pseudotargeted metabolomics analyses for the ovaries showed that the metabolite levels in the POI group, mainly lipids, glycerophospholipids, steroids, and amino acids changed significantly compared with the controls’, and most of them returned to near-healthy levels after receiving hUCMSC treatment. Meanwhile, we also observed an increase of monosaccharide levels in the ovaries from POI mice and a decrease after stem cell treatment. CONCLUSIONS: hUCMSCs restore ovarian function through activating the PI3K pathway by promoting the level of free amino acids, consequently improving lipid metabolism and reducing the concentration of monosaccharides. These findings provide potential targets for the clinical diagnosis and treatment of POI. |
format | Online Article Text |
id | pubmed-7641864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76418642020-11-05 Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice Zhao, Yan Ma, Jiao Yi, Peiye Wu, Jun Zhao, Feiyan Tu, Wan Liu, Wenjing Li, Tianda Deng, Yan Hao, Jie Wang, Hongmei Yan, Long Stem Cell Res Ther Research BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian dysfunction that seriously affects a woman’s physiological health and reproduction. Mesenchymal stem cell (MSC) transplantation offers a promising treatment option for ovarian restoration in rodent POI models. However, the efficacy and mechanism of it remain unclear. METHODS: POI mice model was generated by cyclophosphamide and busulfan, followed with the treatment of tail-vein injection of the human umbilical cord mesenchymal stem cells (hUCMSCs). Maternal physiological changes and offspring behavior were detected. To reveal the pathogenesis and therapeutic mechanisms of POI, we first compared the metabolite profiles of healthy and POI ovarian tissues using untargeted metabolomics analyses. After stem cell therapy, we then collected the ovaries from control, POI, and hUCMSC-treated POI groups for lipid metabolomics and pseudotargeted metabolomics analysis. RESULTS: Our results revealed remarkable changes of multiple metabolites, especially lipids, in ovarian tissues after POI generation. Following the transplantation of clinical-grade hUCMSCs, POI mice exhibited significant improvements in body weight, sex hormone levels, estrous cycles, and reproductive capacity. Lipid metabolomics and pseudotargeted metabolomics analyses for the ovaries showed that the metabolite levels in the POI group, mainly lipids, glycerophospholipids, steroids, and amino acids changed significantly compared with the controls’, and most of them returned to near-healthy levels after receiving hUCMSC treatment. Meanwhile, we also observed an increase of monosaccharide levels in the ovaries from POI mice and a decrease after stem cell treatment. CONCLUSIONS: hUCMSCs restore ovarian function through activating the PI3K pathway by promoting the level of free amino acids, consequently improving lipid metabolism and reducing the concentration of monosaccharides. These findings provide potential targets for the clinical diagnosis and treatment of POI. BioMed Central 2020-11-04 /pmc/articles/PMC7641864/ /pubmed/33148334 http://dx.doi.org/10.1186/s13287-020-01972-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhao, Yan Ma, Jiao Yi, Peiye Wu, Jun Zhao, Feiyan Tu, Wan Liu, Wenjing Li, Tianda Deng, Yan Hao, Jie Wang, Hongmei Yan, Long Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title | Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title_full | Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title_fullStr | Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title_full_unstemmed | Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title_short | Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
title_sort | human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641864/ https://www.ncbi.nlm.nih.gov/pubmed/33148334 http://dx.doi.org/10.1186/s13287-020-01972-5 |
work_keys_str_mv | AT zhaoyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT majiao humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT yipeiye humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT wujun humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT zhaofeiyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT tuwan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT liuwenjing humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT litianda humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT dengyan humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT haojie humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT wanghongmei humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice AT yanlong humanumbilicalcordmesenchymalstemcellsrestoretheovarianmetabolomeandrescueprematureovarianinsufficiencyinmice |